Comparative results in 1991 and in 2001
| . | Data analysis 1991 . | P . | Data analysis 2001 . | P . | ||
|---|---|---|---|---|---|---|
| Cyclosporin dose . | Cyclosporin dose . | |||||
| 1 mg . | 5 mg . | 1 mg . | 5 mg . | |||
| No. of patients randomized | 41 | 40 | 41 | 40 | ||
| Relapsed (%) | 6 (15) | 15 (38) | .01 | 6 (15) | 17 (43) | .005 |
| Alive (%) | 24 (59) | 15 (37) | .05 | 20 (49) | 11 (27) | .04 |
| Causes of death | ||||||
| Relapse (%) | 6 (15) | 15 (37) | .01 | 6 (15) | 17 (43) | .005 |
| TRM (%) | 1 (27) | 10 (25) | .5 | 15 (37) | 12 (30) | .3 |
| Median FU (y) | 2.7 | 1.7 | 13.1 | 12.1 | ||
| Range (y) | (0.9-3.8) | (0.7-3.6) | (11.4-14.2) | (11.0-14.0) | ||
| . | Data analysis 1991 . | P . | Data analysis 2001 . | P . | ||
|---|---|---|---|---|---|---|
| Cyclosporin dose . | Cyclosporin dose . | |||||
| 1 mg . | 5 mg . | 1 mg . | 5 mg . | |||
| No. of patients randomized | 41 | 40 | 41 | 40 | ||
| Relapsed (%) | 6 (15) | 15 (38) | .01 | 6 (15) | 17 (43) | .005 |
| Alive (%) | 24 (59) | 15 (37) | .05 | 20 (49) | 11 (27) | .04 |
| Causes of death | ||||||
| Relapse (%) | 6 (15) | 15 (37) | .01 | 6 (15) | 17 (43) | .005 |
| TRM (%) | 1 (27) | 10 (25) | .5 | 15 (37) | 12 (30) | .3 |
| Median FU (y) | 2.7 | 1.7 | 13.1 | 12.1 | ||
| Range (y) | (0.9-3.8) | (0.7-3.6) | (11.4-14.2) | (11.0-14.0) | ||
FU indicates follow-up in years; TRM, transplantation-related mortality; GvHD, graft-versus-host disease.